ArticlePloS one2016

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.

Eric Lefebvre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.